Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone versus placebo before elective PTCA in type 2 diabetes or insulin resistance
2006-002237-20Phase 2Completed
- Sponsor
- Takeda
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM), insulin resistance (IR) and coronary arteriosclerosis comparing Pioglitazone with Placebo (2 arms). Primary endpoint: Incidence of cardiac troponin I elevation. Started Jun 2006; status: completed.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)insulin resistance (IR)coronary arteriosclerosis
Beyond the preview
Go deeper on 2006-002237-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002237-20.